PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
A E Lang Selected Research
Parkinson Disease (Parkinson's Disease)
11/2007
Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.
10/2006
Mirror movements in Parkinson's disease: effect of dopaminergic drugs.
10/2005
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
01/2003
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
12/2002
Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's disease.
10/2002
Subthalamic DBS replaces levodopa in Parkinson's disease.
08/2001
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
07/2001
Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.
07/2001
Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.
06/2001
Olanzapine for psychosis in Parkinson's disease.
05/2001
Acute orthostatic hypotension when starting dopamine agonist therapy in parkinson disease: the role of domperidone therapy.
01/2001
Pallidotomy for Parkinson's disease.
06/2000
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease.
05/2000
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
04/2000
Relationship of lesion location to cognitive outcome following microelectrode-guided pallidotomy for Parkinson's disease: support for the existence of cognitive circuits in the human pallidum.
04/2000
Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.
04/2000
Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease.
01/2000
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease.
Articles by Research Topic
Disease
18
Parkinson Disease (Parkinson's Disease)
11/2007 - 01/2000
5
Dystonia (Limb Dystonia)
07/2003 - 03/2000
4
Dyskinesias (Dyskinesia)
02/2007 - 04/2000
2
Torticollis (Wryneck)
02/2007 - 08/2004
2
Myoclonus (Nocturnal Myoclonus)
07/2003 - 03/2000
1
Hyperhomocysteinemia
06/2006
1
Orthostatic Hypotension (Postural Hypotension)
05/2001
1
Tics (Tic)
03/2001
1
Scoliosis
06/2000
Drug/Important Bio-Agent (IBA)
6
Levodopa (L Dopa)
FDA Link
Generic
02/2007 - 04/2000
3
Dihydroxyphenylalanine (Dopa)
IBA
06/2002 - 04/2000
2
Dopamine Agonists (Dopamine Agonist)
IBA
11/2007 - 05/2001
2
Apomorphine
IBA
07/2001 - 04/2000
2
GTP Cyclohydrolase (GTP Cyclohydrolase I)
IBA
06/2000 - 04/2000
1
Dopamine Agents (Dopaminergic Agents)
IBA
10/2006
1
Vitamins
IBA
06/2006
1
entacapone (Comtan)
FDA Link
06/2006
1
Sarcoglycans (beta Sarcoglycan)
IBA
07/2003
1
Glucose (Dextrose)
FDA Link
Generic
08/2001
1
Amoxapine (Asendin)
FDA Link
Generic
07/2001
1
olanzapine (Zyprexa)
FDA Link
06/2001
1
Domperidone (Domperidon)
IBA
05/2001
1
Botulinum Toxins (Botulinum Toxin)
IBA
03/2001
1
ropinirole (Requip)
FDA Link
Generic
05/2000
1
Dopamine Receptors (Dopamine Receptor)
IBA
03/2000
Therapy/Procedure
6
Deep Brain Stimulation
02/2007 - 01/2000
5
Pallidotomy
12/2002 - 04/2000
1
Microelectrodes
04/2000